Log In
Print this Print this

multiple biomarker methylation-based prognostic test

  Manage Alerts
Collapse Summary General Information
Company Castle Biosciences Inc.
DescriptionMultiple biomarker methylation-based prognostic test
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDetermine the grade of glioma brain tumors
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today